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Background/aim: For the early stage of nonsmall-cell lung cancer, surgical resection provides the best survival, but the surgical risk
generally increases with age because of the increased prevalence of comorbidities, especially cardiovascular disorders. The aim of this
study was to compare survival and mortality rates of two groups with different ages, younger and older than 70 years, who went curative
resection for nonsmall-cell lung cancer.
Materials and methods: We analyzed the patients who underwent curative lung cancer surgery in the Department of Thoracic Surgery
of Gaziantep University Research Hospital between January 1997 and November 2014. Patients were divided into 2 groups according
to their ages.
Results: A total of 497 patients were included in data analysis (381 were under 70 years old and 116 of them were ≥70 years old). The
older group showed a 1.4-fold increased risk of mortality hazard ratio when the probability of survival was analyzed by histological type,
lymph node involvement, disease stage, and age.
Conclusion: There was no distinct increase in 30-day mortality rates of patients with nonsmall-cell lung cancer who were ≥70 years old,
but the hazard rate for long-term survival was higher in the older group. Curative pulmonary resections due to lung cancer should be
carefully performed in septuagenarians.
Key words: Nonsmall-cell lung cancer, survival rate, elderly

1. Introduction
Currently lung cancer is the leading cause of cancer-related
deaths among both men and women (1). Despite advances
in radiotherapy and chemotherapy treatments, surgery
remains the treatment of choice for nonsmall-cell lung
cancer (NSCLC) that provides the best survival and cure
rates (2). More than half of the patients diagnosed with
NSCLC are older than 65 years and approximately 30% are
over 70 years of age (3).
Although improvements in anesthesia and
postoperative care encourage physicians to perform
surgery, the cardiovascular and pulmonary comorbidities
frequently encountered in the elderly population as
well as their reduced performance increase the risk of
postoperative complications (4).
* Correspondence: ilknurgs@gmail.com

In the present retrospective study, we aimed to evaluate
the impact of advanced age on mortality, morbidity, and
survival among patients undergoing curative surgery for
NSCLC at a single center.
2. Materials and methods
This study was conducted in accordance with the principles
set forth in the Helsinki Declaration and the Patient
Rights Regulations and was approved by the Gaziantep
University Medical Faculty Ethics Committee. Cases of
NSCLC among patients who underwent curative surgery
at our clinic between January 1997 and November 2014
were reviewed retrospectively. Patients with nonstandard
resection such as wedge resection were excluded. While
patients undergoing bilobectomy were considered as

307

AYTEKİN et al. / Turk J Med Sci
lobectomy, with right-sided pneumonectomy representing
34% of all pneumonectomies. In the older group, 15
patients had pneumonectomy and 46 had lobectomy, with
a 24% frequency of right-sided pneumonectomy (Table 1).
The overall survival of all patients was analyzed using
a log-rank test, which showed significantly longer survival
for patients undergoing lobectomy compared to survival
in patients with pneumonectomy (P = 0.001).
When survival following lobectomy was compared
between the two age groups, no significant difference
was observed (P = 0.325). The 5-year survival rate after
lobectomy was 49.9% in the younger group and 46.5% in
the older group.
For pneumonectomy, the younger group was found to
have significantly lower survival than the older group (P
= 0.024). There was no statistically significant difference
between the survival times of patients undergoing rightsided or left-sided pneumonectomy (P = 0.104). Five-year
survival rates after right-sided pneumonectomy were
30.5% in the younger group and 31.1% in the older group;
the difference was statistically nonsignificant (P = 0.235).
Postoperative mortality rates were 7.1% in the older
group and 9.5% in the younger group. The relevant

lobectomy cases, patients with extended pneumonectomy
represented pneumonectomy cases.
All patients were analyzed with respect to age, sex, stage
and histological type of cancer, type of surgical operation
performed, complications, and postoperative mortality
(30 days) and survival rates. Patients were divided into
two groups based on age: Group 1 consisted of patients
younger than 70 years of age (n = 381) and Group 2
included patients ≥70 years of age (n = 116).
Categorical variables were analyzed using the
chi-square test to compare two different groups. The
probability of survival was estimated by the Kaplan–Meier
method and the effects of other variables were assessed
using hazard regression models. All statistical analyses
were conducted using SPSS 22.0 for Windows and P < 0.05
was considered significant.
3. Results
The study included a total of 497 patients, including 463
males and 34 females. Of these, 116 were included in the
older group and 381 in the younger group. The mean age
of patients was 60.88 years (range: 23–84). In the younger
group, 130 patients had pneumonectomy and 251 had
Table 1. Patients’ characteristics.
Group 1, younger (n = 381)

Group 2, older (n = 116)

n

%

n

%

57.23

-

72.84

-

Female

23

6%

11

9.5%

Male

358

94%

105

90.5%

Right side

213

55.9%

61

52.6%

Left side

168

44.1%

55

47.4%

Lobectomy

251

65.9%

80

69%

Pneumonectomy

130

34.1%

36

31%

Squamous cell carcinoma

212

55.9%

75

64.7%

Adenocarcinoma

105

27.7%

28

24.1%

Others

62

16.4%

13

11.2%

1–2

246

75.9%

78

24.1%

3–4

135

78.0%

38

22.0%

Average age
Sex

Side of the tumor

Surgical procedure

Histology

Stage
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P-value was 0.395, indicating a statistically nonsignificant
difference. The overall morbidity rate for both groups was
23.1% (17.7% for the younger group and 5.4% for the older
group). The most common complication was prolonged
air leak, which occurred at a rate of 5% (younger group, n
= 18; older group, n = 7). Bronchopleural fistula occurred
in 22 patients in the younger group and 2 patients in the
older group. Expansion fault occurred in 5 patients in the
younger group and 4 patients in the older group. Atrial
fibrillation was seen in 6 patients in Group 1 and 3 in Group
2. Pulmonary edema occurred in 6 patients in the younger
group and 1 in the older group. Empyema occurred in 7
patients in the younger group and none in the older group.
Other surgical complications were chylothorax, atelectasis,
hematoma, myocardial infarction, pneumonia, acute renal
failure, hemothorax, pneumothorax, aspergilloma, anxiety,
nephrotic syndrome, paresis of the recurrent nerve, and
tumor embolism.
Based on postoperative histopathological examination,
cases were classified as squamous cell carcinoma,
adenocarcinoma, and others. Squamous cell carcinoma
was the most common pathological type detected in both
groups. Distribution of histological types was well balanced

with no statistically significant difference between the two
groups (P = 0.208)
Pathological staging performed according to the 2009
TNM staging system showed that 10.2% of cases were
Stage 1a and 13.3% were Stage 1b; corresponding values
were 14.6% and 20.6% respectively (Figures 1 and 2).
When the survival of patients in both age groups was
analyzed with respect to stages, no difference was found
between the survival times of stage 3 and stage 4 patients (P
= 0.245). A shorter survival was found for the older group
when survival times of stage 1 and stage 2 patients were
compared between the two groups (statistically significant
difference, P = 0.031), as shown in Table 2.
4. Discussion
Currently, there is an increasing number of studies that
assess NSCLC surgery and its outcomes in patients of
advanced age. Geriatric oncologic surgery has become
even more important as a result of the increased life
expectancy of the population.
In a series of 726 patients, Cerfolio and Bryant looked at
5-year survival rates and reported that these were 51% for
NSCLC patients over 70 years of age and 58% for younger

Figure 1. Survival rates of stage 1 and 2 patients.
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Figure 2. Survival Rates for stage 3 and 4 patients.

Table 2. Median survival in age groups according to stages.

Stage

1–2

3–4

Age groups

Median (IQR) survival

Std. error

<70

115.764

6.746

≥70

55.359

5.975

Overall

108.142

6.094

<70

73.425

8.073

≥70

63.048

14.635

Overall

71.527

7.209

patients (5). In another study involving 126 NSCLC
patients, Birim et al. found that the 5-year survival rate was
37% and median survival was 3.8 years (6). However, in a
separate series involving 762 patients who were surgically
treated for NSCLC, Bryant and Cerfolio found a 5-year
survival rate of 51% among patients younger than 45
years of age who were surgically treated for NSCLC and
62% in patients older than 45 years of age (7). Leo et al.
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Log-rank test
P
0.031

0.245

reported a survival rate of 17.5% for patients over 70 years
of age and 53.6% for patients younger than 70 years of age
(8). In our patient series, 3-year survival rates were 50%
in the younger group and 45.8% in the older group and
the corresponding figures for 5-year survival were 45.6%
and 38.5%, respectively. A survival analysis by age group
yielded a P-value of 0.052. Age alone was not found to be a
statistically significant factor for survival.
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A hospital mortality rate of 1.9% was reported by
Suemitsu et al. in a study conducted with 756 patients (9).
In Rostad et al.’s study, the reported postoperative mortality
rate was 9% (10). In our patient series, postoperative
mortality rates were 7.1% in the younger group and 9.5%
in the older group. Although older patients in the present
study showed a higher rate of postoperative mortality, the
difference was not statistically significant (P = 0.395).
Hospital mortality was 3.2% in a series of 126 NSCLC
patients in Birim et al.’s study and 58% of patients were
reported to experience complications. The most common
complication was arrhythmia, occurring at a rate of
31%, followed by prolonged air leak, reported for 21% of
patients (6).
In a study involving 727 NSCLC patients published by
Ogawa et al., a higher incidence (49%) of postoperative
complications was reported among patients 75 years of age
and older versus the comparative group (11).
In contrast, postoperative complications occurred at a
rate of 17.7% in the younger group and 5.4% in the older
group in our patient series. Due to two reasons, some of the
pulmonary complications were seen in a large number of
patients in the younger group. First, the number of young
patients was much higher than the number of patients in
the older group, and the second reason is related to the
characteristics of the young patients. The young patients
had many more comorbidities than older patients (e.g.,
previous lung diseases, diabetes mellitus, coronary
bypass). The most common complication was prolonged
air leak, followed by bronchopleural fistula. More rigorous
preoperative preparation undertaken for elderly patients
might have resulted in lower rates of complications in the
older group.
The type of resection was not reported to be a
determining factor for survival in Suemitsu et al.’s study
and no considerable difference was found between
pneumonectomy and other types of resection with

regard to survival (6). Higher mortality rates were
reported by several studies particularly for right-sided
pneumonectomy (10,12). Schneider et al.’s study found a
mortality rate of 1.4% for lobectomy resections and 4.3%
for pneumonectomy (13).
For our patient series, 5-year mortality rates after
lobectomy were 49.9% in the younger group and 46.5% in
the older group when survival was analyzed according to
the type of resection. Five-year mortality rates were 37.3%
and 21% respectively following pneumonectomy.
All pneumonectomy and lobectomy operations were
compared between groups with regard to survival and
patients undergoing lobectomy in both groups (younger
or older than 70 years of age) were found to have a longer
survival. P-values were 0.014 for the younger group and
0.004 for the older group.
Multivariable analysis was conducted and the history
of smoking, chronic obstructive pulmonary disease, and
pathological stage were identified as factors that affected
survival but no association was found between survival
and histological type, sex, or type of resection (6). In the
present study, patients ≥70 years of age showed a 1.4-fold
increased risk of mortality hazard when the probability
of survival was analyzed by histological type, lymph node
involvement, disease stage, and age. Histological types
other than squamous cell carcinoma were found to be
associated with a 1.5-fold increased risk of mortality.
Considering lymph node involvement, a significant
difference was found between patients with N2 disease
and patients with N0 disease with a hazard ratio of 1.8.
In brief, N2 involvement, age greater than 70 years, and a
histological type other than squamous cell carcinoma were
identified as poor prognostic factors for survival as shown
in Table 3.
While a number of recent studies reported no
significant difference between sublobar resection and
lobectomy with respect to survival of patients, lobectomy

Table 3. Multivariate analyses of median survival.

Risk factors

P

Hazard
ratio

95.0% CI for hazard ratio
Lower

Upper

Age ≥70 vs. <70

0.017*

1.408

1.062

1.866

Adenocarcinoma vs. squamous cell carcinoma

0.133

0.793

0.586

1.073

Other groups vs. squamous cell carcinoma

0.006*

1.576

1.137

2.184

Lymph node N1 vs. N0

0.065

1.321

0.983

1.776

Lymph node N2 vs. N0

0.001*

1.882

1.365

2.596

Lymph node N3 vs. N0

0.145

4.395

0.600

32.179

*: Statistically significant.
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is still considered as a minimally invasive type of oncologic
resection (14). For this reason, sublobar resections were
excluded from the present study.
The patients over 70 years old were selected cautiously.
They had fewer comorbidities than the younger group
(bronchiectasis, tuberculosis, cavitary lung diseases,
diabetes mellitus, coronary bypass surgery, renal failure),
and these comorbidities were not considered in statistical
analyses. This was the limitation of our study.

In conclusion, in the current study, no significant
difference was found in short-term morbidity and
mortality between patients younger or older than 70
years of age who underwent surgical treatment for the
management of NSCLC based on a comparative analysis
of mortality, morbidity, and survival data. Similarly, the
younger and older groups did not differ significantly with
regard to long-term morbidity and mortality.
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